Ocular shares fall on mixed Q3 results

Shares in Ocular Therapeutix (NSDQ:OCUL) fell yesterday after the company beat sales expectations but missed earnings estimates on Wall Street with its third quarter results. The Bedford, Mass.-based company posted a net loss of -$15.6 million on sales of $520,ooo for the 3 months ended Sept. 30, for bottom-line loss of -62% on sales growth of 8.3% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Ocular shares fall on mixed Q3 results appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations Implants MassDevice Earnings Roundup Pharmaceuticals Wall Street Beat oculartherapeutix Source Type: news